Skip to content
Saroja Pharma Industries logo

Saroja Pharma Industries

SAROJA NSE
₹38.80 unchanged 0.00 (0.00%)
Market Cap
₹15.60 Cr

Saroja Pharma Industries (SAROJA) share price was ₹38.80 at the 28 Oct 2026 close; market capitalisation ₹15.60 Cr; sector Chemicals. The share price fell 9.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 10.4% year on year to ₹31.47 Cr and net profit was ₹1.04 Cr, against ₹0.70 Cr a year earlier (compared with Mar 2025). Promoters held 73.02% of Saroja Pharma Industries in Sep 2026, unchanged from Mar 2026.

Close 28 Oct 2026 ₹38.80 −4.35 −10.08% 1Y

Key Fundamentals

SMEChemicals & PetrochemicalsChemicals
Market Cap
₹15.60 Cr
EBITDA
₹3.80 Cr
Return on Equity
9.34%
Debt to Equity
0.83
Book Value
₹43.00
EPS (TTM)
—
52W High
₹43.30
52W Low
₹28.00

Price-based figures as of 29 Oct 2026, 09:09 IST · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,368.1052.581,39,256 Cr12.861.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,248.0077.1246,664 Cr5.970.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,359.5054.2642,878 Cr10.790.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,578.2089.0120,947 Cr8.530.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,487.0025.8920,282 Cr3.470.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹462.5531.5916,772 Cr2.820.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,154.5019.6615,176 Cr2.310.55%10.95%13.54%7,185 Cr788 Cr
Saroja Pharma Industries (this company)
₹38.80—16 Cr0.900.00%9.34%14.97%——
Median 8 companies₹1,532.6052.5820,614 Cr4.720.21%9.36%12.85%7,185 Cr784 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

2
  • Stock is trading at 0.95 times its book value
  • Debtor days have improved from 139 to 90.0 days.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.62% over last 3 years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Neutral

Bearish
7
Neutral
5
Bullish
7

Moving Averages

Neutral

Bearish
5
Neutral
0
Bullish
5

Growth Rate

Revenue Growth
30.24% higher than 3Y

change over 1 year

Net Income Growth
60% higher than 3Y

change over 1 year

Cash Flow Change
547%

change over 1 year

EBITDA Margin Change
-1.81%

change over 1 year Operating margin 7.72% · Mar 2026

Quarterly Results

Particulars Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
26.54
23.73
21.12
19.36
18.79
35.11
38.76
31.47
Expenses
25.18
22.28
19.95
18.17
17.58
33.34
37.39
29.04
Operating Profit
1.36
1.45
1.17
1.19
1.21
1.77
1.37
2.43
OPM %
5.12%
6.11%
5.54%
6.15%
6.44%
5.04%
3.53%
7.72%
Other Income
0.08
0
0.39
0
0
0
0
0
Interest
0.68
0.64
0.83
0.62
0.69
0.72
0.53
0.93
Depreciation
0
0.07
0.04
0.06
0.05
0.06
0.06
0.05
PBT
0.76
0.74
0.69
0.51
0.47
0.99
0.78
1.45
Tax %
27.63%
27.03%
27.54%
27.45%
27.66%
29.29%
26.92%
28.28%
Net Profit
0.55
0.54
0.5
0.38
0.34
0.7
0.57
1.04
EPS (₹)
1.9
1.84
1.24
0.95
0.85
1.74
1.42
2.59
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
36.66
55.63
50.19
40.67
53.73
70.13
Expenses
35.36
53.53
47.47
38.11
50.95
66.32
Operating Profit
1.3
2.1
2.72
2.56
2.78
3.81
OPM %
3.55%
3.77%
5.42%
6.29%
5.17%
5.43%
Other Income
0.09
0.32
0.16
0.19
0.19
0.02
Interest
0.33
0.8
1.32
1.45
1.41
1.49
Depreciation
0.02
0.05
0.07
0.09
0.11
0.11
PBT
1.04
1.57
1.49
1.21
1.45
2.23
Tax %
28.85%
28.03%
28.86%
27.27%
28.97%
27.8%
Net Profit
0.73
1.14
1.06
0.88
1.03
1.61
EPS (₹)
73
3.93
3.61
2.19
2.56
4
Div. Payout %
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.01
0.23
2.94
4.02
4.02
4.02
Reserves
0.93
3.8
2.15
10.62
11.66
13.27
Borrowings
3.02
6.14
10.18
5.73
9.46
14.41
Other Liabilities
4.26
5.34
6.07
6.2
14.41
10.04
Total Liabilities
8.22
15.51
21.34
26.57
39.55
41.74
Fixed Assets
0.09
0.34
2.22
2.51
2.51
2.18
CWIP
0
0
1.79
6.13
8.61
20.34
Investments
0
0.04
0.14
0.2
0.34
0.54
Other Assets
8.13
15.13
17.19
17.73
28.09
18.68
Total Assets
8.22
15.51
21.34
26.57
39.55
41.74
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-1.05
-3.67
2.19
1.02
1.15
7.44
Investing
-0.05
-0.34
-4.82
-4.76
-2.7
-11.68
Financing
1.03
4.27
2.73
3.7
1.56
4.25
Net Cash Flow
-0.07
0.26
0.1
-0.04
0.01
0.01
Free Cash Flow
-1.1
-3.97
-1.54
-3.71
-1.45
-4.06
CFO/EBITDA
-58
-154
96
53
56
212
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
71.88
91.73
80.8
146
181
90.04
Inventory Days
7.23
3.41
31.18
4.1
0.75
4.92
Days Payable
45.43
38.52
47.22
57.45
103
48.43
Cash Conversion Cycle
33.68
56.62
64.76
92.39
78.76
46.52
Working Capital Days
22.2
33.07
17.16
71.71
29.89
5.88
ROCE %
—
33.55%
22.09%
14.93%
12.57%
13.41%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Saroja Pharma Industries insights

56 extracted metrics + investor summaries across FY21–FY26.

Shareholding Pattern

Promot.73.02%Others4.02%Public22.96%As ofSep 2026

Documents

Frequently Asked Questions about Saroja Pharma Industries

What does Saroja Pharma Industries India Ltd do?
Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]
Where is Saroja Pharma Industries India Ltd (SAROJA) listed?
Saroja Pharma Industries India Ltd trades as SAROJA on the NSE.
Which sector does Saroja Pharma Industries India Ltd belong to?
Saroja Pharma Industries India Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd has a market capitalisation of ₹15.6 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Saroja Pharma Industries India Ltd?
Over the last 52 weeks Saroja Pharma Industries India Ltd has traded between ₹28 and ₹43.3 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Saroja Pharma Industries India Ltd?
Saroja Pharma Industries India Ltd reported a return on equity of 9.34%. Its debt-to-equity ratio is 0.83.

Company Information

Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]

Website sarojapharma.com
Listed 2023-09-13
Face Value ₹ 10
Shares Outstanding 40,20,486

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SAROJA.md for Saroja Pharma Industries India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month